c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines

E A Harrington1, M R Bennett, A Fanidi

  • 1Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund Laboratories, London, UK.

The EMBO Journal
|July 15, 1994
PubMed

Insights

Dereguled c-Myc expression triggers apoptosis in fibroblasts, but survival factors like insulin-like growth factors can prevent this cell death. This regulation is independent of cell growth signals.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Dereguled expression of the c-Myc oncogene is implicated in various cancers.
  • Understanding the mechanisms of c-Myc-induced apoptosis is crucial for cancer therapy development.

Purpose of the Study:

  • To investigate how deregulated c-Myc expression induces apoptosis in serum-deprived fibroblasts.
  • To identify factors that inhibit Myc-induced apoptosis and elucidate the underlying mechanisms.

Main Methods:

  • Utilized serum-deprived fibroblast cell cultures.
  • Investigated the effects of specific cytokines, including insulin-like growth factors (IGFs) and platelet-derived growth factor (PDGF).
  • Assessed apoptosis inhibition across different cell cycle phases and in drug-induced cell cycle arrest.

Main Results:

  • Cytokines, particularly IGFs and PDGF, inhibit c-Myc-induced apoptosis in low serum conditions.
  • Cytokine-mediated protection is independent of their growth-promoting abilities.
  • Apoptosis inhibition occurs in post-commitment cell cycle phases (S/G2/M) and in cells with drug-induced cell cycle arrest.
  • Insulin-like growth factor 1 (IGF-I) inhibition of apoptosis proceeds without protein synthesis, indicating no requirement for immediate early gene expression.

Conclusions:

  • c-Myc-induced apoptosis is a physiological process regulated by the availability of survival factors, not a result of conflicting growth signals.
  • Survival factors play a critical role in modulating c-Myc's apoptotic function.
  • These findings have implications for understanding mammalian cell growth regulation in vivo and potential therapeutic strategies targeting c-Myc-driven cancers.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...